The RB-related gene Rb2/p130 in neuroblastoma dierentiation and in B-myb promoter down-regulation

Cell Death and Differentiation

Volumn 5, Issue 5, 1998, Pages 401-407

  Raschellà, Giuseppe ^a   Tanno, Barbara ^a   Bonetto, Francesco ^b   Negroni, Anna ^a   Claudio, Pier Paolo ^c,e   Baldi, Alfonso ^c,e   Amendola, Roberto ^a   Calabretta, Bruno ^d   Giordano, Antonio ^c,d,e   Paggi, Marco G ^b  

^a ENEA   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e FOX CHASE CANCER CENTER   (United States)

Author keywords

Differentiation B myb; E2F; Neuroblastoma; Rb2 p130; Retinoblastoma family

Indexed keywords

DIMETHYL SULFOXIDE; NUCLEAR FACTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; DNA SYNTHESIS; DOWN REGULATION; GENETIC TRANSFECTION; MOUSE; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; TUMOR SUPPRESSOR GENE;

ANIMALIA; MURINAE;

EID: 7344254104     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400359     Document Type: Article

References (59)

1. Baldi A, De LuCa A, Claudio PP, Baldi F, Giordano GG, Tommasino M, Paggi MG and Giordano A (1995) The Rb2/p130 gene product is a nuclear protein whose phosphorylation is cell cycle regulated. J. Cell Biochem. 59: 402-408
2. 1 cyclin complexes. Genes Dev 9. 1340-1353
3. Beijersbergen RL, Kerkhoven RM, Zhu L. Cariée L, Voorhoeve PM and Bernards R (1994) E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo Genes Dev 8 2680-2690
4. Bennett GS and DiLullo C (1985) Expression of a neurofilament protein by the precursors of a subpopulation of ventral spinal cord neurons. Dev. Biol. 107:94-106
5. Bies J, Hoffman B, Amanullah A, Giese T and Wolff L (1996) B-Myb prevents growth arrest associated with terminal differentiation of monocytic cells. Oncogene 12: 355-363
6. Cao L, Faha B, Dembski M, Tsai LH, Harlow E and Dyson N (1992) Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature 355: 176-179
7. Chen PL, Riley DJ, Chen-Kiang S and Lee WH (1996) Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6. Proc. Natl. Acad. Sci. USA 93: 465-469
8. Chen PL, Riley DJ and Lee WH (1995) The retinoblastoma protein as a fundamental mediator of growth and differentiation signals Crit. Rev. Eukaryot. Gene Expr. 5: 79-95
9. Chen PL, Scully P, Shew JY, Wang JY and Lee WH (1989) Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58: 1193-1198
10. Claudio PP, Howard CM, Baldi A, De Luca A, Fu Y, Condorelli G, Sun Y, Colburn N, Calabretta B and Giordano A (1994) p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107. Cancer Res. 54: 5556-5560
11. Cobrinik D, Lee MH, Hannon G, Mulligan G, Bronson RT, Dyson N, Harlow E, Beach D, Weinberg RA and Jacks T (1996) Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev. 10: 1633-1644
12. Cobrinik D, Whyte P, Peeper DS, Jacks T and Weinberg RA (1993) Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes Dev. 7: 2392-2404
13. Coppola JA, Lewis BA and Cole MD (1990) Increased retinoblastoma gene expression is associated with late stages of differentiation in many different cell types. Oncogene 5: 1731-1733
14. Elledge RM and Lee WH (1995) Life and death by p53. 17. 923-930
15. Everson TC (1964) Spontaneous regression of cancer. Ann. NY Acad Sci. 114:721-735
16. Ginsberg D, Vairo G, Chittenden T, Xiao Z-X, Xu G, Wydner KL, DeCaprio JA, Lawrence JB and Livingston DM (1994) E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev. 8: 2665-2679
17. Gu W, Schneider JW, Condorelli G, Kaushal S, Mahdavi V and Nadal Ginard B (1993) Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72:309-324
18. Harris CC (1996) Structure and function of the p53 tumor suppressor gene: Clues for rational cancer therapeutic stratagies. J. Natl. Cancer Inst. 88: 1442-1455
19. Helman LJ, Thiele CJ, Linehan WM, Nelkin BD, Baylin SB and Israel MA (1987) Molecular markers of neuroendocrine development and evidence of environmental regulation. Proc. Natl. Acad. Sci. USA 84:2336-2339
20. Hijmans EM, Voorhoeve PM, Beijersbergen RL, Van't Veer LJ and Bernards R (1995) E2F-5, a new E2F family member that interacts with p130 in vivo. Mol. Cell. Biol. 15: 3082-3089
21. Huang HJ, Yee JK, Shew JY, Chen PL, Bookstein R, Friedmann T, Lee EY and Lee WH (1988) Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science 242: 1563-1566
22. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA and Weinberg RA (1992) Effects of an Rb mutation in the mouse Nature 359: 295-300
23. Johnson DG (1995) Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity. Oncogene 11: 1685-1692
24. Kimhi Y, Palfrey C, Spector I, Barak Y and Littauer UZ (1976) Maturation of neuroblastoma cells in the presence of dimethylsulfoxide. Proc Natl. Acad. Sci. USA 73: 462-466
25. Klein G (1987) The approaching era of the tumor suppressor genes. Science 238: 1539-1545
26. Kraneburg O, Scharnhorst V. van der Eb AJ and Zantema A (1995) Inhibition of cyclin-dependent kinase activity triggers neuronal differentiation of mouse neuroblastoma cells. J. Cell Biol. 131: 227-234
27. Lam EW, Bennett JD and Watson RJ (1995) Cell-cycle regulation of human B-myb transcription. Gene 160: 277-281
28. Lam EW and Watson RJ (1993) An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription. EWBO J. 12: 2705-2713
29. Larcher JC, Basseville M, Vayssiere JL, Cordeau-Lossouarn L, Croizat B and Gros F (1992) Growth inhibition of N1E-115 mouse neuroblastoma cells by c-myc or N-myc antisense oligodeoxynucleotides causes limited differentiation but is not coupled to neurite formation. Biochem. Biophys. Res. Commun. 185 915-924
30. Lee EYHP, Hu N, Yuan S-SF, Cox LA, Bradley A, Lee W-H and Herrup K (1994) Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes Dev. 8: 2008-2021
31. Lee EY, Chang CY, Hu N, Wang YC, Lai CC, Herrup K, Lee WH and Bradley A (1992) Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis [see comments]. Nature 359: 288-294
32. Liebermann DA, Hoffman B and Steinman RA (1995) Molecular controls of growth arrest and apoptosis: p53-dependentand independent pathways. Oncogene 11: 199-210
33. 1 arrest Proc. Natl. Acad. Sci. USA 91: 10079-10083
34. Mancini MA, Shan B, Nickerson JA Penman S and Lee WH (1994) The retinoblastoma gene product is a cell cycle-dependent, nuclear matrix-associated protein. Proc. Natl. Acad. Sci. USA 91: 418-422
35. Martelli F, Cenciarelli C, Santarelli G, Polikar B, Felsani A and Caruso M (1994) MyoD induces retinoblastoma gene expression during myogenic differentiation. Oncogen 9 3579-3590
36. Mittnacht S and Weinberg RA (1991) G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment. Cell 65: 381-393
37. Noble JR, Willetts KE, Mercer WE and Reddel RR (1992) Effects of exogenous wild-type p53 on a human lung carcinoma cell line with endogenous wild-type p53. Exp Cell Res. 203: 297-304
38. Paggi MG, Baldi A, Bonetto F and Giordano A (1996) Retinoblastoma protein family in cell cycle and cancer: A review. J. Cell. Biochem. 62. 418-430
39. Pertile P, Baldi A, De Luca A, Bagella L, Virgilio L, Pisano MM and Giordano A (1995) Molecular cloning, expression, and developmental characterization of the murine retinoblastoma-related gene Rb2/p130. Cell Growth Differ. 6. 1659-1664
40. Portier MM, Croizat B and Gros F (1982) A sequence of changes in cytoskeletal components during neuroblastoma differentiation. FEBS Lett. 146: 283-288
41. Raschellà G, Negroni A, Pucci S, Amendola R, Valen S and Calabretta B (1996) B-myb transcriptional regulation and mRNA stability during differentiation of neuroblastoma cells. Exp. Cell Res. 222: 395-399
42. Raschella G, Negroni A, Sala A, Pucci S. Romeo A and Calabretta B (1995) Requirement of B-myb function for survival and differentiative potential of human neuroblastoma cells. J. Biol. Chem 270. 8540-8545
43. Raschella G. Tanno B, Bonetto F, Amendola R, Battista T, De Luca A, Giordano A and Paggi MG (1997) Retinoblastoma-reiated protein pRb2/p130 and its binding to the B-myb promoter increase during human neuroblastoma differentiation J. Cell Biochem. 67: 293-303
44. Richon VM, Lyle RE and McGehee RE, Jr (1997) Regulation and expression of retinoblastoma proteins p107 and p130 during 3T3-L1 adipocyte differentiation J. Biol. Chem 272: 10117-10124
45. Riley DJ, Lee EYHP and Lee W-H (1994) The retinoblastoma protein: More than a tumor suppressor. Annu. Rev. Cell Biol. 10:1-29
46. Ronde M, Warthoe P, Gjetting T, Lukas J. Bartek J and Strauss M (1996) The retinoblastoma protein modulates expression of genes coding for diverse classes of proteins including components of the extracellular matrix. Oncogene 12: 2393-2401
47. Sala A and Calabretta B (1992) Regulation of BALB/c 3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression. Proc. Natl. Acad. Sci. USA 89. 10415-10419
48. Sala A, Casella I, Bellon T, Calabretta B, Watson RJ and Peschle C (1996a) B-myb promotes S phase and is a downstream target of the negative regulator p107 in human cells J Biol. Chem. 271:9363-9367
49. Sala A, De Luca A, Giordano A and Peschle C (1996b) The retinoblastoma family member p107 binds to B-MYB and suppresses its autoregulatory activity. J. Biol Chem. 271 28738-28740
50. Sang N, Baldi A and Giordano A (1995) The roles of tumor suppressors pRb and p53 in cell proliferation and cancer. Mol. Cell Diff. 3. 1-29
51. Schwab M (1993) Amplification of N-myc as a prognostic marker for patients with neuroblastoma. Semin. Cancer Biol 4 13-18
52. Shirodkar S, Ewen ME, DeCaprio JA, Morgan J, Livingston DM and Chittenden T (1992) The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner Cell 68: 157-166
53. Sidle A, Palaty C, Dirks P, Wiggan O, Kiess M. Gill RM, Wong AK and Hamel PA (1996) Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation. Cnt Rev. Biochem. Mol. Biol. 31: 237-271
54. Tsokos M, Scarpa S, Ross RA and Triche TJ (1986) Differentiation of human neuroblastoma recapitulates neural crest development - Study of morphology, neurotransmitter enzymes, and extracellular-matrix proteins Am. J Pathol. 128: 434-496
55. Vairo G, Livingston DM and Ginsberg D (1995) Functional interaction between E2F-4 and p130: Evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev. 9. 869-881
56. Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81: 323-330
57. Weiss WA, Aldape K Mohapatra G, Feuerstein BG and Bishop JM (1997) Targeted expression of MYCN causes neuroblastoma in transgenic mice EMBO J. 16: 2985-2995
58. Zhu L, van den Heuvel S, Helin K, Fattaey A, Ewen ME, Livingston DM, Dyson N and Harlow E (1993) Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev. 7: 1111-1125
59. Zwicker J, Liu NS, Engeland K, Lucibello FC and Müller R (1996) Cell cycle regulation of E2F site occupation in vivo. Science 271: 1595-1597